Literature DB >> 24491259

Quantum mechanical studies of DNA and LNA.

Troels Koch1, Irene Shim, Morten Lindow, Henrik Ørum, Henrik G Bohr.   

Abstract

Quantum mechanical (QM) methodology has been employed to study the structure activity relations of DNA and locked nucleic acid (LNA). The QM calculations provide the basis for construction of molecular structure and electrostatic surface potentials from molecular orbitals. The topologies of the electrostatic potentials were compared among model oligonucleotides, and it was observed that small structural modifications induce global changes in the molecular structure and surface potentials. Since ligand structure and electrostatic potential complementarity with a receptor is a determinant for the bonding pattern between molecules, minor chemical modifications may have profound changes in the interaction profiles of oligonucleotides, possibly leading to changes in pharmacological properties. The QM modeling data can be used to understand earlier observations of antisense oligonucleotide properties, that is, the observation that small structural changes in oligonucleotide composition may lead to dramatic shifts in phenotypes. These observations should be taken into account in future oligonucleotide drug discovery, and by focusing more on non RNA target interactions it should be possible to utilize the exhibited property diversity of oligonucleotides to produce improved antisense drugs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24491259      PMCID: PMC3962643          DOI: 10.1089/nat.2013.0465

Source DB:  PubMed          Journal:  Nucleic Acid Ther        ISSN: 2159-3337            Impact factor:   5.486


  55 in total

1.  Solution structure of an LNA hybridized to DNA: NMR study of the d(CT(L)GCT(L)T(L)CT(L)GC):d(GCAGAAGCAG) duplex containing four locked nucleotides.

Authors:  K E Nielsen; S K Singh; J Wengel; J P Jacobsen
Journal:  Bioconjug Chem       Date:  2000 Mar-Apr       Impact factor: 4.774

2.  Potent and nontoxic antisense oligonucleotides containing locked nucleic acids.

Authors:  C Wahlestedt; P Salmi; L Good; J Kela; T Johnsson; T Hökfelt; C Broberger; F Porreca; J Lai; K Ren; M Ossipov; A Koshkin; N Jakobsen; J Skouv; H Oerum; M H Jacobsen; J Wengel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

3.  Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid.

Authors:  J D WATSON; F H CRICK
Journal:  Nature       Date:  1953-04-25       Impact factor: 49.962

4.  Predicting protein interaction sites: binding hot-spots in protein-protein and protein-ligand interfaces.

Authors:  Nicholas J Burgoyne; Richard M Jackson
Journal:  Bioinformatics       Date:  2006-03-07       Impact factor: 6.937

5.  PCSK9 LNA antisense oligonucleotides induce sustained reduction of LDL cholesterol in nonhuman primates.

Authors:  Marie W Lindholm; Joacim Elmén; Niels Fisker; Henrik F Hansen; Robert Persson; Marianne R Møller; Christoph Rosenbohm; Henrik Ørum; Ellen M Straarup; Troels Koch
Journal:  Mol Ther       Date:  2011-11-22       Impact factor: 11.454

6.  Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide.

Authors:  P C Zamecnik; M L Stephenson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

Review 7.  Cellular delivery of antisense oligonucleotides.

Authors:  I Lebedeva; L Benimetskaya; C A Stein; M Vilenchik
Journal:  Eur J Pharm Biopharm       Date:  2000-07       Impact factor: 5.571

8.  Biochemical characterization of interactions between DNA polymerase and single-stranded DNA-binding protein in bacteriophage RB69.

Authors:  Siyang Sun; Yousif Shamoo
Journal:  J Biol Chem       Date:  2002-11-27       Impact factor: 5.157

9.  Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides.

Authors:  C Beltinger; H U Saragovi; R M Smith; L LeSauteur; N Shah; L DeDionisio; L Christensen; A Raible; L Jarett; A M Gewirtz
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

10.  Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents.

Authors:  C A Stein; J Bo Hansen; Johnathan Lai; SiJian Wu; Anatoliy Voskresenskiy; Anja Høg; Jesper Worm; Maj Hedtjärn; Naira Souleimanian; Paul Miller; Harris S Soifer; Daniella Castanotto; Luba Benimetskaya; Henrik Ørum; Troels Koch
Journal:  Nucleic Acids Res       Date:  2009-10-23       Impact factor: 16.971

View more
  7 in total

Review 1.  The chemical evolution of oligonucleotide therapies of clinical utility.

Authors:  Anastasia Khvorova; Jonathan K Watts
Journal:  Nat Biotechnol       Date:  2017-02-27       Impact factor: 54.908

2.  Residue interactions affecting the deprotonation of internal guanine moieties in oligodeoxyribonucleotides, calculated by FMO methods.

Authors:  Julio C González-Olvera; Absalom Zamorano-Carrillo; Gerardo Arreola-Jardón; Reynaldo C Pless
Journal:  J Mol Model       Date:  2022-01-25       Impact factor: 1.810

3.  Electronic Structures of LNA Phosphorothioate Oligonucleotides.

Authors:  Henrik G Bohr; Irene Shim; Cy Stein; Henrik Ørum; Henrik F Hansen; Troels Koch
Journal:  Mol Ther Nucleic Acids       Date:  2017-06-01       Impact factor: 8.886

Review 4.  Guidelines for Rational Cancer Therapeutics.

Authors:  Byunghee Yoo; Ann-Marie Billig; Zdravka Medarova
Journal:  Front Oncol       Date:  2017-12-12       Impact factor: 6.244

Review 5.  Advanced In vivo Use of CRISPR/Cas9 and Anti-sense DNA Inhibition for Gene Manipulation in the Brain.

Authors:  Brandon J Walters; Amber B Azam; Colleen J Gillon; Sheena A Josselyn; Iva B Zovkic
Journal:  Front Genet       Date:  2016-01-12       Impact factor: 4.599

6.  Refining LNA safety profile by controlling phosphorothioate stereochemistry.

Authors:  Erik Daa Funder; Nanna Albæk; Annie Moisan; Sabine Sewing; Troels Koch
Journal:  PLoS One       Date:  2020-06-12       Impact factor: 3.240

Review 7.  Gene editing in the context of an increasingly complex genome.

Authors:  K Blighe; L DeDionisio; K A Christie; B Chawes; S Shareef; T Kakouli-Duarte; C Chao-Shern; V Harding; R S Kelly; L Castellano; J Stebbing; J A Lasky-Su; M A Nesbit; C B T Moore
Journal:  BMC Genomics       Date:  2018-08-08       Impact factor: 3.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.